Importer of Controlled Substances Registration, 95647 [2016-31273]

Download as PDF 95647 Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices Controlled substance Drug code Meperidine ............................................................................................................................................................... Meperidine intermediate-B ....................................................................................................................................... Methadone ............................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... Morphine .................................................................................................................................................................. Thebaine .................................................................................................................................................................. Oxymorphone .......................................................................................................................................................... Alfentanil .................................................................................................................................................................. Remifentanil ............................................................................................................................................................. Sufentanil ................................................................................................................................................................. Carfentanil ................................................................................................................................................................ Tapentadol ............................................................................................................................................................... Fentanyl ................................................................................................................................................................... The company plans to manufacture bulk controlled substances for use in product development of analytical reference standards, for distribution to its customers. Drug Enforcement Administration [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: ACTION: [FR Doc. 2016–31285 Filed 12–27–16; 8:45 am] Notice of registration. Registrants listed below have applied for and been granted registration by the Drug Enforcement SUMMARY: BILLING CODE 4410–09–P Company sradovich on DSK3GMQ082PROD with NOTICES Rhodes Technologies ........................................................... Bellwyck Clinical Services .................................................... Cerilliant Corporation ............................................................ Noramco, Inc ........................................................................ Cody Laboratories, Inc ......................................................... AMRI Rensselaer, Inc .......................................................... ALMAC Clinical Services Incorp (ACSI) .............................. Fresenius Kabi USA, LLC .................................................... Akorn, Inc ............................................................................. Actavis Laboratories FL, Inc ................................................ Unither Manufacturing LLC .................................................. Cambrex Charles City .......................................................... United States Pharmacopeial Convention ........................... R & D Systems, Inc .............................................................. Catalent CTS, LLC ............................................................... VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. FR docket The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has II. II. II. II. II. II. II. II. II. II. II. II. II. Administration (DEA) as importers of various classes of schedule I or II controlled substances. DEPARTMENT OF JUSTICE Importer of Controlled Substances Registration Dated: December 20, 2016. Louis J. Milione, Assistant Administrator. 9230 9233 9250 9273 9300 9333 9652 9737 9739 9740 9743 9780 9801 Schedule 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR 46956 54603 57933 57932 54602 54603 54602 54601 57935 54602 61250 63222 63220 64509 66081 Published ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: December 19, 2016. Louis J. Milione, Assistant Administrator. [FR Doc. 2016–31273 Filed 12–27–16; 8:45 am] July 19, 2016. August 16, 2016. August 24, 2016. August 24, 2016. August 16, 2016. August 16, 2016. August 16, 2016. August 16, 2016. August 24, 2016. August 16, 2016. September 6, 2016. September 14, 2016. September 14, 2016. September 20, 2016. September 26, 2016. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before February 27, 2017. DATES: Drug Enforcement Administration Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: ADDRESSES: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc. ACTION: PO 00000 Notice of application. Frm 00093 Fmt 4703 Sfmt 4703 The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Page 95647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31273]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: 
    The companies listed below applied to be registered as importers of 
various basic classes of controlled substances. Information on 
previously published notices is listed in the table below. No comments 
or objections were submitted and no requests for hearing were submitted 
for these notices.

----------------------------------------------------------------------------------------------------------------
                 Company                             FR docket                          Published
----------------------------------------------------------------------------------------------------------------
Rhodes Technologies......................  81 FR 46956.................  July 19, 2016.
Bellwyck Clinical Services...............  81 FR 54603.................  August 16, 2016.
Cerilliant Corporation...................  81 FR 57933.................  August 24, 2016.
Noramco, Inc.............................  81 FR 57932.................  August 24, 2016.
Cody Laboratories, Inc...................  81 FR 54602.................  August 16, 2016.
AMRI Rensselaer, Inc.....................  81 FR 54603.................  August 16, 2016.
ALMAC Clinical Services Incorp (ACSI)....  81 FR 54602.................  August 16, 2016.
Fresenius Kabi USA, LLC..................  81 FR 54601.................  August 16, 2016.
Akorn, Inc...............................  81 FR 57935.................  August 24, 2016.
Actavis Laboratories FL, Inc.............  81 FR 54602.................  August 16, 2016.
Unither Manufacturing LLC................  81 FR 61250.................  September 6, 2016.
Cambrex Charles City.....................  81 FR 63222.................  September 14, 2016.
United States Pharmacopeial Convention...  81 FR 63220.................  September 14, 2016.
R & D Systems, Inc.......................  81 FR 64509.................  September 20, 2016.
Catalent CTS, LLC........................  81 FR 66081.................  September 26, 2016.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each company's 
maintenance of effective controls against diversion by inspecting and 
testing each company's physical security systems, verifying each 
company's compliance with state and local laws, and reviewing each 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed persons.

    Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-31273 Filed 12-27-16; 8:45 am]
 BILLING CODE 4410-09-P